The PRISMA Study, carried out in Italy, demonstrated the reduction of HbA1c by structured SMBG combined with a dashboard illustrating mean pre- and post-meal blood glucose and magnitude of postprandial glucose excursion over 4 consecutive weeks in non-insulin-treated patients with type 2 diabetes [18]. This evidence concerns the gene INS and type 2 diabetes mellitus.